These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10647762)

  • 81. Tinzaparin sodium: a low-molecular-weight heparin.
    Neely JL; Carlson SS; Lenhart SE
    Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism].
    Nielsen HK; Lassen JF; Ravn HB; Husted SE
    Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
    Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.
    Doyle DJ; Turpie AG; Hirsh J; Best C; Kinch D; Levine MN; Gent M
    Ann Intern Med; 1987 Oct; 107(4):441-5. PubMed ID: 3307582
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
    Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H
    Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice.
    Zidane M; van Hulsteijn LH; Brenninkmeijer BJ; Huisman MV
    Haematologica; 2006 Aug; 91(8):1052-8. PubMed ID: 16885045
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The acute management of venous thromboembolism in pregnancy.
    Greer IA
    Curr Opin Obstet Gynecol; 2001 Dec; 13(6):569-75. PubMed ID: 11707659
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
    Graif A; Kimbiris G; Grilli CJ; Agriantonis DJ; Putnam SG; Leung DA
    J Vasc Interv Radiol; 2020 Apr; 31(4):537-543. PubMed ID: 31959518
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin in the geriatric patient population.
    Merli GJ
    Clin Geriatr Med; 2001 Feb; 17(1):93-106. PubMed ID: 11270136
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Postoperative Deep Vein Thrombosis, Pulmonary Embolism, and Myocardial Infarction: Complications After Therapeutic Anticoagulation in the Patient With Spine Trauma.
    Shiu B; Le E; Jazini E; Weir TB; Costales T; Caffes N; Paryavi E; O'Hara N; Gelb DE; Koh EY; Ludwig SC
    Spine (Phila Pa 1976); 2018 Jul; 43(13):E766-E772. PubMed ID: 29215498
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.
    Hettiarachchi RJ; Prins MH; Lensing AW; Buller HR
    Curr Opin Pulm Med; 1998 Jul; 4(4):220-5. PubMed ID: 10813237
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fixed-dose versus adjusted-dose low molecular weight heparin for the initial treatment of patients with deep venous thrombosis.
    Harenberg J
    Curr Opin Pulm Med; 2002 Sep; 8(5):383-8. PubMed ID: 12172440
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study.
    Popov J; Coelho S; Carrier M; Sperlich C; Solymoss S; Routhier N; Shivakumar S; Aibibula W; Kahn SR; Tagalakis V
    J Thromb Haemost; 2022 Aug; 20(8):1868-1874. PubMed ID: 35587536
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study.
    Monreal M; Lafoz E; Ruiz J; Callejas JM; Arias A
    Eur J Vasc Surg; 1994 Sep; 8(5):584-9. PubMed ID: 7813725
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Treatment of venous thromboembolism.
    Eichinger S
    Wien Med Wochenschr; 2005 Jan; 155(1-2):7-10. PubMed ID: 15773736
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.
    O'Brien B; Levine M; Willan A; Goeree R; Haley S; Blackhouse G; Gent M
    Arch Intern Med; 1999 Oct; 159(19):2298-304. PubMed ID: 10547169
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Thromboembolism].
    Fitzmaurice DA; Hobbs FD
    Vasa; 2001 May; 30(2):141-5. PubMed ID: 11417288
    [No Abstract]   [Full Text] [Related]  

  • 100. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study.
    Boccalon H; Elias A; Chalé JJ; Cadène A; Gabriel S
    Arch Intern Med; 2000 Jun; 160(12):1769-73. PubMed ID: 10871969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.